Joseph M. Galvin - Publications

Combined epicardial substrate ablation and pulsed field pulmonary vein isolation in Brugada syndrome.

Journal: HeartRhythm case reports

Published: August 21, 2026

Regression of massive left ventricular hypertrophy in Danon disease.

Journal: Acta cardiologica

Published: February 11, 2026

Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: December 30, 2025

Predictors for increasing genetic testing yields in hypertrophic cardiomyopathy.

Journal: Irish journal of medical science

Published: March 04, 2025

Defining Cardiomyocyte Repolarization Response to Pharmacotherapy in Long-QT Syndrome Type 3.

Journal: Journal of the American Heart Association

Published: October 08, 2024

Refractory inappropriate sinus tachycardia treated with pulsed field ablation of the sinus node: A breath of fresh air.

Journal: Heart rhythm

Published: September 03, 2024

Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction.

Journal: Circulation. Genomic and precision medicine

Published: February 14, 2024

Streamlining atrial fibrillation ablation management using a digitization solution.

Journal: European heart journal. Digital health

Published: February 08, 2024

Long-term results of ablation index guided atrial fibrillation ablation: insights after 5+ years of follow-up from the MPH AF Ablation Registry.

Journal: Frontiers in cardiovascular medicine

Published: November 03, 2023

Refractory Inappropriate Sinus Tachycardia Treated with Pulsed-field Ablation of the Sinus Node: A Breath of Fresh Air.

Journal: The Journal of innovations in cardiac rhythm management

Published: October 19, 2023

Diagnostic yield from cardiac gene testing for inherited cardiac conditions and re-evaluation of pre-ACMG variants of uncertain significance.

Journal: Irish journal of medical science

Published: September 19, 2023

Using Ribonucleoprotein-based CRISPR/Cas9 to Edit Single Nucleotide on Human Induced Pluripotent Stem Cells to Model Type 3 Long QT Syndrome (SCN5A±).

Journal: Stem cell reviews and reports

Published: July 24, 2023